Safety and Effectiveness of Adriamycin and Cyclophosphamide Followed by Dose Dense (Every 2 Weeks) Paclitaxel Given With Trastuzumab as Neoadjuvant Treatment in HER2-Positive Early-Stage Breast Cancer
Titel:
Safety and Effectiveness of Adriamycin and Cyclophosphamide Followed by Dose Dense (Every 2 Weeks) Paclitaxel Given With Trastuzumab as Neoadjuvant Treatment in HER2-Positive Early-Stage Breast Cancer
Auteur:
Berner-Wygoda, Yael Li, Meredith Perlon, Chloe Malon, Diego Pathak, Neha Di Iorio, Massimo Savill, Jacqueline Aljuhani, Amal Nadler, Michelle B. Amir, Eitan